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 Introduction 
 Mosquitoes transmit numerous human and animal 
diseases with devastating consequences worldwide. Ma-
laria is caused by protozoan  Plasmodium  parasites and 
transmitted to humans by infected female  Anopheles 
 mosquitoes. The mosquito life cycle makes it an ideal dis-
ease vector as most adult females must feed on vertebrate 
blood to acquire nutrients for egg production. However, 
blood feeding also exposes the mosquito to infection from 
protozoan parasites, viruses and nematode worms. A fur-
ther consequence of blood feeding is the dramatic rise in 
levels of endogenous bacteria in the mosquito midgut  [1, 
2] , which puts the mosquito at risk of systemic infection. 
Therefore, the mosquito immune system must defend 
against blood-borne infections and control its midgut 
bacterial populations  [3–5] .
 The  Anopheles gambiae  innate immune system is re-
sponsible for eliminating the majority of invading  Plas-
modium  ookinetes during the midgut stages of mosquito 
infection  [6] . Two key immune proteins involved in anti-
 Plasmodium  defense are Leucine-Rich repeat IMmune 
protein 1 (LRIM1) and APL1C, as shown by striking in-
creases in live parasites when these genes are silenced  [7–
9] . LRIM1 and APL1C are closely related proteins that 
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 Abstract 
 Mosquitoes have potent innate defense mechanisms that 
protect them from infection by diverse pathogens. Much re-
mains unknown about how different pathogens are sensed 
and specific responses triggered. Leucine-Rich repeat 
 IMmune proteins (LRIMs) are a mosquito-specific family of 
putative innate receptors. Although some LRIMs have been 
implicated in mosquito immune responses, the function of 
most family members is largely unknown. We screened 
 Anopheles gambiae  LRIMs by RNAi for effects on mosquito 
infection by rodent malaria and found that LRIM9 is a  Plas-
modium berghei  antagonist with phenotypes distinct from 
family members LRIM1 and APL1C, which are key compo-
nents of the mosquito complement-like pathway. LRIM9 
transcript and protein levels are significantly increased after 
blood feeding but are unaffected by  Plasmodium  or midgut 
microbiota. Interestingly, LRIM9 in the hemolymph is strong-
ly upregulated by direct injection of the ecdysteroid, 20-hy-
droxyecdysone. Our data suggest that LRIM9 may define a 
novel anti- Plasmodium  immune defense mechanism trig-
gered by blood feeding and that hormonal changes may 
alert the mosquito to bolster its defenses in anticipation of 
exposure to blood-borne pathogens. 
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possess leucine-rich repeat (LRR) domains, which are 
found in host defense proteins of many phyla, such as ver-
tebrate Toll-like receptors  [10] . LRIM1 and APL1C circu-
late in the hemolymph as a disulfide-linked heterodimer-
ic complex  [11, 12] . This complex is involved in parasite 
killing through its interaction with the complement-like 
effector protein, TEP1. LRIM1/APL1C binds to proteo-
lytically processed, mature TEP1 (known as TEP1 cut ), 
promoting its stabilization, preventing it from reacting 
with self-tissues and enabling it to opsonize parasites  [11, 
12] . Direct binding of TEP1 cut to the ookinete surface 
 triggers parasite lysis and melanization reactions, result-
ing in parasite killing and clearance  [13] . TEP1, LRIM1 
and APL1C are core members of the mosquito comple-
ment-like pathway, which plays a broad role in innate im-
munity including defense against bacteria  [14] . These 
proteins are constitutively present in the hemolymph, 
bathing the basal labyrinth of the midgut and poised to 
attack malaria parasites as they emerge through invaded 
cells. Interestingly, the LRIM1/APL1C complex has also 
been demonstrated to interact with other TEP family 
members in vitro  including TEP3, TEP4 and TEP9  [15] .
 Bioinformatic searches discovered a novel mosquito-
specific family of proteins related to LRIM1 and APL1C 
 [12, 16] . To date, 24 members of this LRIM family have 
been identified in  An. gambiae.  Orthologs of most LRIMs 
and additional homologous proteins were discovered in 
the genomes of mosquitoes  Aedes aegypti  and  Culex quin-
quefasciatus . However, no LRIM-related genes were found 
in other organisms, including  Drosophila . LRIM members 
share a distinct genomic organization and protein domain 
architecture, which distinguishes them from the larger su-
perfamily of LRR genes. An archetypal LRIM comprises a 
signal peptide, LRR motifs, a conserved pattern of cyste-
ines and a coiled-coil domain. The members are divided 
into four subfamilies based on variations to this core 
structure. Long LRIMs have 10 to 13 LRR motifs, whereas 
Short LRIMs have 6 or 7. Transmembrane LRIMs possess 
a C-terminal transmembrane domain and Coil-less LRIMs 
lack a coiled-coil domain. Interestingly, several LRIMs are 
encoded within tight genomic clusters with evidence of 
local gene shuffling and duplication  [16] . A cluster of 
Short LRIMs found in all three mosquitoes consists of 
 LRIM7 ,  LRIM8 ,  LRIM9  and  LRIM10 .  LRIM8  has dupli-
cated in  An. gambiae  to give  LRIM8A  and  LRIM8B .
 Apart from LRIM1 and APL1C, the other LRIM mem-
bers are largely uncharacterized to date. Certain LRIMs 
have been implicated in innate immunity, including de-
fense against  Plasmodium  and bacteria  [17–21] . It is un-
clear whether the LRIM family represents an adaptation 
to the hematophagous lifestyle of mosquitoes. With their 
versatile LRR domains, we hypothesize that the LRIMs 
are pathogen recognition proteins, and the family has di-
versified to recognize different microbes that mosquitoes 
encounter. This paper aimed to broaden our understand-
ing of the LRIM family in  An. gambiae  by investigating 
whether any uncharacterized LRIMs are involved in anti-
 Plasmodium  defense. We discovered LRIM9 is a novel 
antagonist of  Plasmodium berghei  infections with a strik-
ing expression profile. LRIM9 is highly enriched in adult 
female mosquitoes. Expression of LRIM9 is dramatically 
induced by blood feeding and regulated by ecdysone sig-
naling. Our data suggest that LRIM9 functions via a 
unique immune mechanism independent of the known 
mosquito complement-like pathway. We hypothesize 
that LRIM9 is involved in an anticipatory immune re-
sponse triggered by blood feeding, which defends against 
blood-borne infections such as  Plasmodium . This is an 
original concept in  An. gambiae  innate immunity.
 Materials and Methods 
 Ethics Statement 
 This study was carried out in strict accordance with the United 
Kingdom Animals (Scientific Procedures) Act 1986. The protocols 
for mosquito blood feeding and for infection of mosquitoes with  P. 
berghei  by blood feeding on parasite-infected mice were approved 
and carried out under the UK Home Office License PLL70/7185 
awarded in 2010. The procedures are of mild to moderate severity 
and the numbers of animals used are minimized by incorporation 
of the most economical protocols. Opportunities for reduction, re-
finement and replacement of animal experiments are constantly 
monitored and new protocols are implemented following approv-
al by the Imperial College Ethical Review Committee.
 Mosquito Maintenance, Gene Silencing and Infection 
 An. gambiae  N’gousso and L3–5 strains were maintained, 
blood fed, and assayed for infection with  P. berghei  CON GFP strain 
 [22] as described previously  [15] . Human blood feeding was per-
formed using an artificial membrane feeding system  [23] . Single 
and double knockdown experiments and parasite counts in dis-
sected midguts were performed as described previously  [12] . 
Primers used for synthesis of double-stranded RNA against  LRIM9 
 are as follows with T7 tags in lower case:
 LRIM9  RNAi For: taatacgactcactatagggACTGGCAGAAAAG 
CTTCCAA;
 LRIM9  RNAi Rev: taatacgactcactatagggTGGCATTTTCTCG 
AACACAG.
 Other primers for gene silencing ( GFP ,  LRIM1 ,  TEP1  and 
 CTL4 )  have been reported elsewhere  [23] .
 RNA Extraction and qRT-PCR 
 Total RNA was extracted from 10 whole mosquitoes per sample 
using the TRIzol Reagent (Invitrogen). For the developmental pro-
file, 10 eggs, larvae (2nd or 4th instar) or pupae were used per 
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sample. Total RNA was DNase treated using Turbo DNA-free kit 
(Ambion) and cDNA was synthesized from 1 μg RNA using Super-
Script II kit with oligo(dT) 12–18 primers (Invitrogen). Quantitative 
real-time PCR was performed using the ABI Prism 7500 Fast Real-
Time PCR System, as previously described  [23] . Ribosomal gene 
 S7  was used as the endogenous reference, and gene expression was 
quantitated relative to a calibrator control sample (e.g.  dsGFP -
treated mosquitoes). Primers for  S7  and  LRIM1  have been report-
ed previously  [23] . Primers for  LRIM9  are as follows:
 LRIM9  qRT-PCR F: TTCAGCATGCACTGGAAAAG;
 LRIM9  qRT-PCR R: GTCGGTACCATCGGTTGACT.
 Generation of LRIM9 Antibodies 
 An. gambiae LRIM 9 was cloned into the  pIEx-10  (Novagen) 
expression plasmid in-frame with the plasmid signal peptide for 
secretion, an N-terminal Strep tag and a C-terminal 10× His tag as 
follows: first a DNA fragment containing  LRIM9  was amplified by 
PCR from genomic DNA using the primers:
 LRIM9  F: TGCAATTTTCGATTCAGTGC;
 LRIM9  R: AAAGGACCCACATCTCAACG.
 The 1,583-bp product was used as a PCR template using prim-
ers containing overhangs for ligase-independent cloning:
 LRIM9  LIC F: gacgacgacaagatgGAGATTTCCAGCTCCGT 
GGTG;
 LRIM9  LIC R: gaggagaagcccggtttGGCAGACGGTTCGGA 
CGCCAC.
 The resulting expression construct encodes a 445-amino acid 
fragment of  LRIM9  removing its endogenous signal sequence and 
stop (LRIM9 HIS ).
 A cell line stably expressing LRIM9 HIS was selected using G418 
by cotransfecting Sf9 cells with  pIEx-10-LRIM9  and  pIE1-neo  (No-
vagen) plasmids as described previously  [24] . LRIM9 HIS was affinity 
purified from 2 l of 0.22 μ M sterile-filtered conditioned medium us-
ing a 5 ml HisTrap FF column on an ÄKTA purifier (GE Healthcare). 
After binding, the column was washed with buffer A (1× phosphate-
buffered saline, PBS + 0.1% triton, 40 m M imidazole, pH 8.0) and the 
captured protein was eluted with buffer B (1× PBS + 500 m M imid-
azole, pH 8.0) and then concentrated using an Amicon Ultra cen-
trifugal filter (Millipore). Purified LRIM9 HIS was analyzed by SDS-
PAGE followed by Coomassie staining and quantified by Bradford 
assay. Approximately 215 μg of LRIM9 HIS was used to immunize 
guinea pigs for antibody production (Eurogentec). The pre-immune 
and immune sera were evaluated using Western blotting (see below).
 Additionally, a rabbit anti-peptide antibody was generated 
against the C-terminal peptide NH 2 -CDYARRLEVASEPSAK-
COOH (Eurogentec). A second peptide against the internal pep-
tide NH 2 -DSDGTLLDKSTDGTDC-COOH was unsuccessful. 
These were used for some initial experiments but were replaced by 
the more sensitive whole-protein antibody, described above.
 Hemolymph Collection, Western Blot and Binding Assays 
 Hemolymph was collected from groups of individual mosqui-
toes as previously described  [12] . Final sample volume was adjust-
ed to 1 mosquito/μl; 10 mosquitoes per lane were used for SDS-
PAGE and Western blot analysis. An exception was the CLIPA8 
cleavage experiment, where 1.5 mosquito/μl and 15 mosquitoes 
per lane were used. Western blotting with SRPN3, TEP1 and 
APL1C antibodies was performed as previously described  [12] . 
Positive LRIM9 guinea pig serum was used at 1/500 dilution in 
PBS + 3% milk and 0.05% Tween-20 for 1 h at room temperature. 
The TEP1 binding assay was performed using transfected Sua4.0 
cells, as detailed previously  [12] . Cells were transfected with 
pIEx10-LRIM9 HIS , pIEx10-GFP secreted HIS and pIEx10-APL1C HIS .
 Mosquito Fecundity Experiment 
 Upon eclosion, mosquitoes were given 3 days to mate in a 30-
cm 3 population cage prior to injection with double-stranded RNA. 
Three days after injection, females were allowed to feed on an anes-
thetized mouse. After 48 h, a group of mosquitoes was dissected to 
examine blood meal digestion and ovary development. After 72 h, 
the remaining mosquitoes were placed in 50-mm Petri dishes on 
filter paper saturated with 0.1% saline. Dishes were stored at 27  °  C 
in darkness for 24 h to encourage oviposition, after which mosqui-
toes were removed and eggs were counted by direct observation 
under a dissecting microscope. Egg dishes were then half-filled 
with 0.1% saline, dusted with powdered fish food and incubated at 
27   °   C for 3 days to allow hatching. Larvae were counted by direct 
observation under a dissecting microscope.
 Bacterial and Ecdysone Challenge Experiments 
 Ampicillin-resistant  Escherichia coli  OP-50 was grown in Luria-
Bertani (LB) broth, harvested during logarithmic growth phase, 
washed with PBS and resuspended in PBS to give an optical density 
at 600 n M (OD 600 ) of 0.4  [25] . Female mosquitoes were injected with 
69 nl of bacterial suspension. Bacterial viability was confirmed by 
counting colonies formed overnight at 37   °   C after plating cells onto 
LB agar. The bacterial proliferation assay was performed as previ-
ously described  [25] , except with 24 h between bacterial inoculation 
and sample collection. For survival assays, the number of dead mos-
quitoes was monitored daily for 10 days after bacterial injection. Chal-
lenge with bioparticles was performed as described previously  [24] . 
CLIPA8 cleavage was assayed in hemolymph samples analyzed under 
reducing conditions, as described previously  [26] . Female mosqui-
toes were injected with 69 nl of a 14.5 μg/μl suspension of 20-hy-
droxyecydsone (Sigma) in sterile PBS. This dose was shown to elicit 
a maximal increase in protein synthesis in the fat body in vitro  [27] .
 Antibiotic Treatment 
 For 4 days prior to blood feeding, newly eclosed mosquitoes 
were given 10% sucrose supplemented with 10 U/ml penicillin, 10 
μg/ml streptomycin and 15 μg/ml gentamicin  [3] . Efficacy of anti-
biotic treatment was assayed by plating homogenates of cohorts of 
5 mosquitoes on LB agar and counting the colonies formed after 
incubation at 27  °  C for 2 days.
 VectorBase Gene Identifiers 
 VectorBase Gene Identifiers were as follows: LRIM9, 
AGAP007453; LRIM1, AGAP006348; APL1C, AGAP007033; TEP1, 
AGAP010815; TEP3, AGAP010816; TEP4, AGAP010812; TEP9, 
AGAP010830; CTL4, AGAP005335; CLIPA8, AGAP010731; vitello-
genin, AGAP004203; lipophorin, AGAP001826; S7, AGAP010592; 
SRPN3, AGAP006910.
 Results 
 LRIM9 Is a Novel Plasmodium Antagonist 
 To elucidate whether any uncharacterized  An. gambiae 
 LRIMs play a role in anti- Plasmodium  defense, the family 
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was screened for a parasite infection phenotype after gene 
knockdown by RNAi. Parasite numbers were monitored 
7 days after susceptible mosquitoes were infected with 
GFP-expressing  P. berghei . The screen identified LRIM9, 
a Short family member, as a novel antagonist of  P. berghei 
 infections. Silencing  LRIM9  resulted in a significant 3-fold 
increase in live oocysts compared to  dsGFP -treated con-
trols ( fig.  1 a; online suppl. table  1; for all online suppl. 
 material, see www.karger.com/doi/10.1159/000365331). 
However, there was no change in the proportion of in-
fected mosquitoes (prevalence).  LRIM9  was efficiently si-
lenced with 84% average reduction in the transcript (on-
line suppl. fig. 1) lasting for at least 7 days (data not shown).
 To further investigate the role of LRIM9 in parasite 
melanization, the gene was silenced in two  An. gambiae 
 experimental models that are refractory to  P. berghei  in-
fection where virtually all of the invading ookinetes are 
melanized. In L3–5 mosquitoes, a laboratory-selected re-
fractory strain  [28] , silencing  LRIM9  resulted in a signifi-
cant decrease in the number of melanized parasites but 
did not produce live oocysts ( fig. 1 b, online suppl.  table 2). 
In contrast, silencing  LRIM9  did not alter the outcome of 
infection in susceptible mosquitoes following silencing of 
 CTL4  ( fig.  1 c, online suppl. table  3). In this refractory 
model, silencing  CTL4  alone or in combination with 
 LRIM9  led to the same significant decrease in live oocysts 
and increase in melanized ookinetes. In comparison, si-
lencing  CTL4  in combination with  TEP1  completely 
blocked melanization induced by  CTL4  silencing and re-
sulted in a large increase in the number of live oocysts, 
consistent with previous observations  [15] . Silencing ef-
ficiency of the  LRIM9  transcript in L3–5 and  CTL4  knock-
down mosquitoes (89 and 76%, respectively) was compa-
rable to the single knockdown in susceptible mosquitoes 
(online suppl. fig. 1).
 LRIM9 Is Adult Female Enriched 
 To initially characterize LRIM9, we examined its devel-
opmental expression profile by quantitative real-time PCR 
(qRT-PCR). RNA was collected from eggs, two larval stages 
(2nd and 4th instar), pupae, newly eclosed, and 4-day-old 
sugar-fed mosquitoes. The transcript was most abundant in 
adult female mosquitoes ( fig. 2 ). Compared to adult males, 
 LRIM9  transcript was greater than 20-fold enriched in adult 
females. The  LRIM9  transcript level was also extremely low 
in eggs, larval and pupal stages. These data suggest that 
LRIM9 functions primarily in adult female mosquitoes.
 LRIM9 Transcript Is Upregulated after Blood Feeding 
 As LRIM9 is female enriched and a  P. berghei  antago-
nist, we investigated whether the  LRIM9  transcript is in-
duced in response to  P. berghei  infection. Indeed, qRT-
 Fig. 1.  LRIM9  is a  P. berghei  antagonist with involvement in mela-
nization. After gene silencing using RNAi, mosquitoes were in-
fected with fluorescent  P. berghei ,  and parasite load was monitored 
after 7 days. Live fluorescent oocysts and melanized ookinetes per 
mosquito  midgut are shown. Horizontal lines indicate the median 
parasite number.  a Infection intensity in ds GFP  and ds LRIM9 -
treated susceptible mosquitoes. Data are pooled from 3 indepen-
dent biological experiments using the N’gousso strain (see online 
suppl. table 1). Asterisk indicates significance using the Kruskal-
Wallis test with Dunn’s post-test (p < 0.05).  b Infection intensity 
in refractory L3–5 mosquitoes after ds GFP  and ds LRIM9  injection. 
These data are representative of 2 independent experiments (see 
online suppl. table 2). Asterisk indicates significance using Mann-
Whitney test (p < 0.05).  c Infection intensity in ds GFP -, ds CTL4 -, 
ds CTL4/TEP1 -  and ds CTL4/LRIM9 -injected susceptible mosqui-
toes. Results shown are representative of 2 independent experi-
ments (see online suppl. table 3). Asterisks indicate significance 
using the Kruskal-Wallis test with Dunn’s post-test (p < 0.001). 
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PCR analysis showed that the  LRIM9  transcript was ro-
bustly upregulated after feeding on infected blood. When 
maintained at 19  °  C, the permissive temperature of  P. ber-
ghei ,  LRIM9  expression peaked at 48 h after feeding, 
where the transcript was 2.6-fold higher than sugar-fed 
controls ( fig. 3 a). Expression returned to baseline levels 
by 72 h. Interestingly, the same regulation was observed 
when mosquitoes fed on uninfected blood revealing that 
 LRIM9  expression is not triggered by parasites, but in-
stead is a consequence of blood feeding.
 LRIM9 Protein Is Present in the Hemolymph and Is 
Enriched after Blood Feeding 
 To gain insights into its function in vivo, an antibody 
was raised against LRIM9 and used to assay hemolymph 
(online suppl. fig. 2). The specific band identified at 50 
kDa is consistent with the predicted size of LRIM9, sug-
gesting that LRIM9, unlike LRIM1, APL1C and LRIM4, 
does not form covalent dimers in the hemolymph  [12, 15] .
 The antibody was next used to determine the temporal 
dynamics of the LRIM9 protein following a blood meal. 
Mosquitoes were given a murine blood meal and main-
tained at 19  °  C. Hemolymph was collected 3, 8, 12, 24, and 
48 h after feeding and analyzed by Western blot ( fig. 3 b). 
Compared to the LRIM1/APL1C complex and SRPN3, 
which both remained relatively stable across all time 
points, LRIM9 was massively enriched in hemolymph af-
ter blood feeding. The earliest induction was observed at 
8 h with a striking peak between 24 and 48 h followed by 
a rapid decrease by 72 h. However, even at 96 h, the LRIM9 
protein was more abundant than it was prior to blood 
feeding.
 Given that LRIM9 protein is so strongly induced by 
blood feeding, RNAi knockdown was measured in blood-
fed mosquitoes (online suppl. fig. 3). Indeed, following 
knockdown, LRIM9 protein levels were significantly re-
duced even after blood feeding with only a very faint band 
detectable. We also found that LRIM9 was upregulated 
when mosquitoes fed on human blood (online suppl. 
fig.  4). Protein abundance peaked at 24 h after human 
blood feeding, which is likely because mosquitoes were 
kept at 27  °  C rather than 19  °  C as in the previous experi-
ment using murine blood.
 We next asked whether LRIM9 upregulation occurs 
after subsequent blood meals or is specific to the first. To 
test this, mosquitoes were allowed to take two consecu-
tive murine blood meals (separated by 96 h), and hemo-
lymph was collected from cohorts 24 h after their first and 
second blood meal. Hemolymph from sugar-fed con-
trols, which were the same age as the blood-fed mosqui-
toes but were not blood fed, was analyzed for comparison. 
Western blot analysis using the LRIM9 antibody demon-
strated that the LRIM9 protein (and transcript, not 
shown) is highly induced after both the first and second 
blood meal, with no obvious dampening of the second 
response ( fig. 3 c).
 LRIM9 Is Not Regulated by Bacteria 
 We then investigated whether LRIM9 induction is 
triggered by the increase in midgut bacteria that occurs 
after blood feeding  [1, 2] . To test this hypothesis, mos-
quitoes were fed a spectrum of antibiotics to significant-
ly reduce their midgut flora prior to blood feeding  [3] . 
LRIM9 protein levels were unaffected by antibiotic 
treatment in both sugar-fed and blood-fed mosquitoes 
( fig. 4 a). These findings suggest that LRIM9 upregula-
tion after blood feeding is independent of the endoge-
nous midgut bacteria. To further test whether LRIM9 is 
bacterial responsive, we performed qRT-PCR after in-
jection of bacteria directly into the hemocoel of sugar-
fed mosquitoes.  LRIM9  transcript was unaffected 24, 48 
and 72 h after  Escherichia coli  (gram-negative bacteria) 
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 Fig. 2.  LRIM9  is enriched in adult female mosquitoes. RNA was 
extracted from  An. gambiae  eggs, larvae (2nd and 4th instar), pu-
pae, newly eclosed female and male mosquitoes (‘young adult’), 
and 4-day-old sugar-fed female and male mosquitoes (‘adult’). Us-
ing synthesized cDNA, qRT-PCR determined  LRIM9  transcript 
levels at each developmental stage.  LRIM9  expression was normal-
ized to  S7  (a constitutively expressed ribosomal gene) and calcu-
lated relative to the young adult female. The mean of 2 indepen-
dent replicates is shown with standard error bars. 
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injection, whereas  LRIM1  was highly induced at 24 and 
48 h ( fig. 4 b). Furthermore,  LRIM9  silencing had no ef-
fect on the number of colony-forming units or the sur-
vival of blood-fed mosquitoes after  E. coli  injection 
( fig. 4 c, d). In contrast, silencing  LRIM1  significantly in-
creased mosquito mortality and bacterial proliferation. 
Finally, silencing  LRIM9  did not affect the bacterial-in-
duced cleavage activation of CLIPA8 ( fig. 4 e), which is 
deemed a functional marker of antibacterial defense  [26, 
29] . Together, these data show that LRIM9 is not regu-
lated by midgut bacteria or infection with exogenous 
bacteria.
 LRIM9 Is Regulated by Ecdysone 
 As we had excluded bacterial regulation, we investi-
gated whether the hormonal changes that occur after 
blood feeding influence LRIM9 regulation. In particu-
lar, the steroid hormone ecdysone drives the transcrip-
tion of many key genes for vitellogenesis. Ecdysone is 
primarily secreted by the ovaries 10–36 h after blood 
feeding (peaking at 24 to 36 h), and is hydroxylated into 
20-hydroxyecdysone (20E)  [30] . As LRIM9 is strongly 
induced by blood feeding, we directly tested whether it 
is 20E responsive. Using qRT-PCR, the  LRIM9  tran-
script was highly induced 24 h after intrathoracic injec-
tion of 20E ( fig. 5 a). The  LRIM1  transcript was relative-
ly unresponsive to both 20E and blood feeding. Further-
more, the LRIM9 protein was strongly enriched in the 
hemolymph in response to 20E injection ( fig.  5 b). In 
contrast to the effect on transcript levels, protein induc-
tion was stronger after blood feeding than after 20E in-
jection. This suggests that in addition to regulating the 
LRIM9 transcript, blood feeding enhances its transla-
tion. A similar effect has been shown previously for 
 Fig. 3. LRIM9 is upregulated after blood feeding at the transcript and 
protein level.  a RNA was extracted from mosquitoes 24, 48 and 72 h 
after feeding on uninfected or  P. berghei- infected murine blood. 
Sugar-fed mosquitoes were used for the baseline expression (0 h). 
 LRIM9  expression was determined using qRT-PCR, normalizing to 
ribosomal  S7  and calculated relative to sugar-fed mosquitoes. The 
mean of 4 independent experiments is shown with standard error 
bars.  b Mosquitoes were allowed to feed on uninfected murine 
blood, and hemolymph was collected after 3, 8, 24, 48, 72 and 96 h. 
Hemolymph was analyzed by Western blot under nonreducing con-
ditions and probed with antibodies against LRIM9, APL1C (to ana-
lyze the LRIM1/APL1C complex) and SRPN3 (as a loading control). 
 c Mosquitoes were given two consecutive murine blood meals 96 h 
apart (1st and 2nd blood meal) and hemolymph was collected 24 h 
after each blood meal. Hemolymph was collected from sugar-fed 
mosquitoes of the same age (but not given either blood meal), for 
comparison. Samples were analyzed by nonreducing Western blot 
using antibodies against LRIM9 and APL1C. 
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blood feeding activation of translation of AaGATAa 
transcripts in the fat body of  Ae. aegypti  [31] . Again, the 
LRIM1/APL1C complex was unresponsive to this treat-
ment. Coomassie staining of samples confirmed that vi-
tellogenin and lipophorin, two nutrient transport pro-
teins known to be regulated by 20E, were induced after 
20E injection ( fig. 5 c).
 As  An. gambiae  female mosquitoes require a blood 
meal to enable egg development, and the 20E targets vitel-
logenin and lipophorin play an important role in this pro-
cess, we hypothesized that, in addition to its role in anti-
 Plasmodium  immunity, LRIM9 may also be involved in 
mosquito reproduction. To examine this possibility, mat-
ed ds GFP - and ds LRIM9 -treated female mosquitoes were 
 Fig. 4. LRIM9 is not regulated by bacteria or involved in antibac-
terial defense.  a Newly emerged mosquitoes were fed either ster-
ile sugar solution or a cocktail of antibiotics dissolved in sugar. 
After 4 days of treatment, some mosquitoes were allowed to feed 
on uninfected murine blood whilst others were kept on sugar. 
After 24 h, hemolymph was collected and analyzed by nonreduc-
ing Western blot, probing with LRIM9 and SRPN3 antibodies. 
 b  RNA was extracted from mosquitoes 24, 48 and 72 h after  E. coli 
 injection.  LRIM9  and  LRIM1  expression was determined by qRT-
PCR, normalizing to ribosomal S7. Expression was normalized to 
injection of sterile PBS at each time point and calculated relative 
to uninjected (0 h) mosquitoes. The mean of 2 independent ex-
periments is shown with standard error bars.  c Mosquitoes were 
injected with ds GFP , ds LRIM9  and ds LRIM1 , blood fed after 
3 days and innoculated with live  E. coli  24 h later. Mosquito sur-
vival was monitored daily for 10 days. Survival was compared to 
ds GFP  using the Kaplan-Meier log-rank test ( * * *   p  < 0.0001). 
 d  Mosquitoes were injected with ds GFP , ds LRIM9  and ds LRIM1 
 and after 4 days injected with live ampicillin-resistant  E. coli . Af-
ter 24 h, batches of 10 mosquitoes were surface sterilized, washed 
and homogenized. The homogenate was plated onto ampicillin 
LB agar and colony-forming units (CFU) were counted after 
overnight incubation at 37   °   C. Mean CFU per mosquito from 3 
independent experiments is shown with standard error bars. 
 ds LRIM9  and ds LRIM1  were compared with ds GFP  using meta-
analysis ( * * *  p < 0.0001).  e Four days after injection of ds GFP , 
ds LRIM9  and ds TEP1 , hemolymph was collected from half of 
these mosquitoes. The other half were injected with  Staphylococ-
cus aureus  bioparticles, and hemolymph was collected 2 h after 
challenge. Hemolymph was analyzed by reducing Western blot 
and probed with antibodies against CLIPA8 and SRPN3 (loading 
control). 
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blood fed and encouraged to lay eggs. Initial microscopic 
analysis of both treatment groups 72 h after blood feeding 
revealed no differences in ovarian development or blood 
meal digestion (data not shown). Furthermore, we found 
that total eggs laid, mean eggs laid per female, larval hatch-
ing and percentage of fertile females were equivalent be-
tween ds GFP  and ds LRIM9  ( table 1 ). Therefore,  LRIM9 
 silencing had no impact on mosquito reproduction or 
blood meal digestion.
 LRIM9 Does Not Interact with TEP1 
 The mosquito complement-like pathway has a well-
established role in parasite killing and melanization. To 
characterize whether LRIM9 functions in this pathway, 
we first investigated whether silencing it affects the stabil-
ity or abundance of LRIM1, APL1C and TEP1. Hemo-
lymph collected from blood-fed mosquitoes following 
 LRIM9  silencing was indistinguishable from the control; 
there was no effect on the abundance of TEP1-F, TEP1 cut , 
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 Fig. 5. LRIM9 is induced after direct injection of 20-hydroxyecdy-
sone. RNA and hemolymph were collected from mosquitoes 24 h 
after intrathoracic injection of PBS or 20-hydroxyecdsone or a mu-
rine blood meal.  a  LRIM9  and  LRIM1  expression in RNA samples 
was measured by qRT-PCR, normalized to ribosomal  S7  and calcu-
lated relative to PBS-injected mosquitoes. The mean of 2 indepen-
dent experiments is shown with standard error bars.  b Hemolymph 
was analyzed by nonreducing Western blot and probed with antibod-
ies against LRIM9 and APL1C (for LRIM1/APL1C).  c Hemolymph 
samples were analyzed by SDS-PAGE and stained with Coomassie. 
 Table 1.  LRIM9 silencing has no effect on egg laying and larval hatching
Gene 
knockdown
Females
at start
Females
laid eggs
Total
eggs laid
Mean eggs
per female
Females 
laid eggs
Hatchability Fertile 
females
GFP 46 27 1,809 67 59% 62% 50%
LRIM9 46 29 1,958 68 63% 64% 52%
 Mosquitoes were allowed to mate, treated with dsGFP and dsLRIM9 and then blood fed. After 72 h, individual females were placed 
in dishes with wet filter paper and encouraged to lay eggs in darkness. The number of eggs laid and larvae hatched were counted. Hatch-
ability is the percentage of eggs that hatched into larvae. Fertile females were defined as those that lay at least one egg and produce at 
least one larva.
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the LRIM1/APL1C complex or the loading control, 
SRPN3 ( fig. 6 a). There was also no effect of  LRIM1  silenc-
ing on LRIM9 abundance or mobility. In contrast, as pre-
viously shown, silencing  LRIM1  abolishes the LRIM1/
APL1C complex and results in loss of TEP1 cut from the 
hemolymph  [11, 12] . These results suggest that LRIM9 
does not interact with TEP1.
 To test this directly, we expressed a recombinant His-
tagged LRIM9 in Sua4.0 cells, a mosquito hemocyte-like 
cell line that naturally secretes endogenous TEP1-F and 
TEP1 cut  [12] . LRIM9 HIS was affinity purified from the 
conditioned medium, and the bound material was as-
sayed for the presence of TEP1 ( fig.  6 b). Interestingly, 
there was no detectable signal for either TEP1-F or 
 TEP1 cut in the bound material, indicating that LRIM9 
does not interact with TEP1. Furthermore, because Sua4.0 
cells endogenously produce the LRIM1/APL1C/TEP1 cut 
complex, the lack of TEP1 signal in the captured material 
also reveals that LRIM9 does not interact with the LRIM1/
APL1C complex. As a positive control, TEP1 cut was ro-
bustly present in samples purified from the conditioned 
medium of APL1C HIS transfected cells. These results in-
dicate that LRIM9 does not directly interact with TEP1. 
Therefore, LRIM9 acts via an unknown immunity mech-
anism independent of the known complement system.
 Discussion 
 Here, we have characterized LRIM9, a novel member 
of the LRIM family in  An. gambiae . LRIM9 was found to 
be a novel antagonist of  P. berghei  infection. However, the 
precise function of LRIM9 in defense against  Plasmodium 
 remains unclear and requires further study. The charac-
teristic LRR and coiled-coil domains of LRIM9 suggest 
involvement in pathogen recognition and interactions 
with other immune proteins  [16, 32, 33] . Our data suggest 
that LRIM9 is not directly involved in the known mos-
quito complement-like pathway. However, LRIM9 might 
interact with other TEP family members or could func-
tion downstream of TEP1. We currently lack a suitable 
assay to test the latter. The observation that  LRIM9  silenc-
ing does not recover live oocysts in refractory L3–5 mos-
quitoes suggests LRIM9 might function downstream of 
parasite lysis/killing mechanisms to promote melaniza-
tion. In  Drosophila , melanization has been shown to in-
crease the efficiency of other immune reactions  [34] and 
the same has been suggested in  An. gambiae  [26] . Mela-
nization has been proposed as a clearance mechanism for 
dead parasites in refractory L3–5 mosquitoes, whereas in 
 CTL4  knockdown mosquitoes parasites are thought to be 
directly killed by melanization  [29] . As silencing  LRIM9 
 has a phenotype in L3–5 mosquitoes but not in the  CTL4 
 knockdown, we believe that LRIM9 is not a component 
of the melanization cascade per se but is promoting rec-
ognition of dead parasites, which then leads to their mel-
anization. It remains to be determined whether LRIM9 is 
itself a scavenger receptor of dead parasites.
 LRIM9 has a unique expression profile: it is enriched 
in adult female mosquitoes and strongly induced by blood 
feeding. Our results correlate well with previous whole-
genome transcriptomics analyses  [35–37] . Mosquitoes 
responded similarly to murine and human blood, which 
indicated that possible causes of upregulation of LRIM9 
may include common mammalian blood components, 
formation of the blood bolus, distension of the gut or sig-
naling occurring after blood feeding.
 We have shown that LRIM9 is regulated by 20E, a ste-
roid hormone secreted by the ovaries in response to blood 
feeding. In agreement with our findings,  LRIM9  expression 
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 Fig. 6. LRIM9 does not interact with the known complement-like 
system.  a Hemolymph was collected from ds GFP -, ds LRIM1 - and 
ds LRIM9 -injected mosquitoes 24 h after an uninfected murine 
blood meal. Samples were analyzed by nonreducing Western blot 
using antibodies against TEP1, SRPN3, LRIM9 and APL1C (for 
LRIM1/APL1C).  b Conditioned medium was collected 3.5 days 
after transfection of Sua4.0 cells with secreted His-tagged GFP 
(sGFP), LRIM9 and APL1C. Tagged proteins and interacting part-
ners were captured from the conditioned medium using metal af-
finity beads. Starting conditioned medium (left panels) and bound 
material (right panels) were analyzed by nonreducing Western 
blot. Two blots were probed with a His probe (top panels) and a 
TEP1 antibody (bottom panels), respectively. 
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is 3-fold higher 24 h after blood feeding in mosquitoes with 
ovaries compared to genetically manipulated ovaryless 
mosquitoes [Magnusson and Crisanti, pers. commun.]. 
The most parsimonious hypothesis is that  LRIM9  is tran-
scriptionally regulated by 20E, and is activated directly by 
the ecdysone receptor or indirectly via an ecdysone-regu-
lated transcription factor. It would be insightful to deter-
mine whether  LRIM9  expression is dramatically reduced 
after 20E injection when the ecdysone receptor is silenced. 
Alternatively, transcript stability, translational repression 
or protein turnover could be regulated by 20E  [38] .
 We have determined that neither midgut bacterial flo-
ra nor exogenous bacteria influence LRIM9 regulation. 
However, the nutrient-sensitive target of rapamycin 
(TOR) pathway, insulin/insulin-like growth factor sig-
naling or microRNAs  [39–41] could feasibly contribute 
to  LRIM9  expression. In mosquitoes, steroid hormones 
and TOR signaling work synergistically to control expres-
sion of yolk protein precursors  [42] .
 Regulation of immune genes by 20E has been observed 
previously in insects. Melanization pathway components, 
such as PPO, are under 20E regulation in  An. gambiae 
 [43, 44] and other blood-feeding insects  [45] . Like LRIM9, 
PPO2, PPO3 and PPO9 are strongly induced after blood 
feeding  [6, 44] . As we demonstrated that LRIM9 can pro-
mote melanization, future studies should investigate a 
possible interaction between LRIM9 and PPO activation. 
Using the genome-wide expression map available for  An. 
gambiae  [46] , we found that LRIM9 and vitellogenin are 
coregulated. Like LRIM9, vitellogenin is regulated by 20E 
and by multiple blood meals  [47–49] . As vitellogenin is 
produced by the mosquito fat body and ecdysone is hy-
droxylated into 20E by this tissue  [30] , we hypothesize 
that LRIM9 is also produced by the fat body. Indeed, pre-
vious microarray analyses demonstrate that  LRIM9  ex-
pression is significantly higher in the fat body compared 
to the midgut or ovaries  [36, 37] . Furthermore,  LRIM9 
 was not enriched in the transcriptome of circulating  An. 
gambiae  hemocytes  [50] . However, this warrants further 
investigation as blood feeding was recently demonstrated 
to induce hemocyte proliferation and activation  [51] . In-
terestingly, vitellogenin in the hemolymph interferes with 
TEP1-mediated killing of  Plasmodium  parasites by re-
ducing the efficiency of TEP1 binding to parasite surfaces 
 [52] . However, we did not observe a link between LRIM9 
and mosquito fecundity or TEP1 levels in the hemo-
lymph. Therefore, LRIM9 is likely to function via a novel 
immunity mechanism.
 We hypothesize that LRIM9 is induced in anticipation 
of blood-borne infections rather than in response to infec-
tion, which is an original concept in  An. gambiae  immu-
nity. In support of this hypothesis, LRIM9 is induced after 
both uninfected and infected blood meals. Hematopha-
gous insects, like mosquitoes, are at high risk of infection 
from blood-borne pathogens, including  Plasmodium  para-
sites, filarial nematodes and viruses. Our proposed theory 
of anticipatory immunity in mosquitoes would be a highly 
important defense mechanism against such infections. By 
assuming every blood meal is infectious and inducing im-
mune effectors, like LRIM9, in anticipation of such infec-
tions, the mosquito does not need to specifically recognise 
each pathogen but is prepared for imminent danger. It is 
unknown whether LRIM9 plays a generalized role or is 
specific to particular blood-borne pathogens, such as  Plas-
modium . Importantly, it should be determined whether 
anticipatory immunity and LRIM9 are involved in defense 
against the human malaria parasite,  P. falciparum .
 In contrast to LRIM9, LRIM1 and APL1C constitutively 
circulate at high levels in the hemolymph poised to attack 
invaders, which has been described as basal immunity  [53] . 
Unlike LRIM9, they are not specific to blood-borne infec-
tions because they are also involved in antibacterial defense 
and phagocytosis  [54] . Basal immunity is able to rapidly 
defend against pathogens that directly enter the hemo-
lymph, such as bacteria and fungi, whereas anticipatory im-
munity is a slower response best suited to protect against 
blood-borne pathogens, which take longer to invade the 
hemolymph. Anticipatory immunity would potentially be 
less energetically costly than basal immunity, whilst still 
providing sufficient protection. Anticipatory immunity 
has not, to our knowledge, been reported in the innate im-
mune response of another organism. Innate immunity is 
traditionally considered to be poorly specific and nonan-
ticipatory. However, the adaptive immune response of ver-
tebrates has been previously proposed as ‘anticipatory’. In 
a mechanism distinct from that in mosquitoes, vertebrates 
generate diverse repertoires of T and B lymphocyte recep-
tors by rearrangement of gene segments to enable recogni-
tion of any potential antigen  [55] .
 By coupling the regulation of LRIM9 with hormonal 
changes that occur after blood feeding, the mosquito en-
hances its immune system at the most opportune time. 
The fascinating link between innate immunity and ste-
roid hormones has been widely observed in vertebrates 
and invertebrates  [56–58] . Steroid hormones, like juve-
nile hormone and 20E, are extremely versatile and able to 
regulate development, growth, reproduction, ageing and 
immunity in insects  [59–62] . It was recently reported that 
20E transferred by male  An. gambiae  mosquitoes during 
mating modulates oogenesis in females  [63] . Although 
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hormonal regulation of insect development is well under-
stood  [64–66] , the mechanisms regulating immunity are 
still being uncovered. In  Drosophila , developmental pro-
duction of 20E regulates the innate immune response via 
a complex network of transcriptional circuits  [67] .
 20E has been shown to regulate the  Drosophila  Imd 
pathway and modulate production of antimicrobial pep-
tides  [68] . Furthermore, 20E controls the expression of 
the pattern recognition receptor, PGRP-LC, which pro-
tects the fly against bacterial infection  [67] . Therefore, re-
duced 20E signaling can severely immunocompromise 
the adult fly. A recent study demonstrated that ecdysone 
is essential for hemocyte activation in  Drosophila  larvae 
and normal immune function  [69, 70] . Without this acti-
vation, larvae were defective in bacterial phagocytosis and 
unable to survive bacterial infection  [69] . Ecdysone has 
also been implicated in the control of hemocyte phagocy-
tosis in  Rhodius prolixus , the Hemipteran vector of Cha-
gas disease  [71] . Importantly, hormone signaling has 
been implicated in the synchronization of different im-
mune responses  [69] , which suggests LRIM9 could be in-
volved in more than one immune function. Future re-
search will aim to shed light on the roles of LRIM9 and 
hormonal regulation in the mosquito’s anticipatory im-
mune response.
 The  LRIM9  promoter could be favorable for transgen-
ic strategies where adult female-specific expression is re-
quired, such as Release of Insects carrying a Dominant 
Lethal (RIDL)  [72] . If the expression profile of LRIM9 in 
 An. gambiae  is conserved in other mosquito species, such 
a strategy could be used to target numerous mosquito-
borne diseases, such as arboviruses and filarial worms, as 
well as malaria. Indeed, using the available data in 
 VectorBase, the  LRIM9  ortholog in  Ae. aegypti 
 (AAEL001414) is also highly expressed in females and in-
duced 12 h after blood feeding  [73] . Furthermore, in all 
three sequenced mosquito genomes,  LRIM9  resides in a 
genomic cluster with other Short LRIMs  (LRIM7 , 
 LRIM8A ,  LRIM8B  and  LRIM10  in  An. gambiae)  [12, 16] . 
Based on extant microarray data, this cluster of Short 
LRIMs seems to share a similar expression profile (with 
the exception of  LRIM7 ) in  An. gambiae  and  Ae. aegypti 
 [35, 37, 73] . Future studies should further investigate 
these Short LRIMs and their relationship with LRIM9 in 
these and other disease vector mosquitoes where they are 
present, such as  Cx. quinquefasciatus  [16] .
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